Human factors validation study of 3 mg sumatriptan autoinjector, for migraine patients.

about

Subcutaneous sumatriptan delivery devices: comparative ease of use and preference among migraineurs.Pen devices for self-injection: contrasting measured injection force with users' perceived ease of injection.

P2860

Q37603685-CBE2550E-5E8A-4A53-A4BC-DB2C12CE458D Q47262735-91CEF076-F2A2-4EFC-AA15-34C6FAD87EF1

P2860

Human factors validation study of 3 mg sumatriptan autoinjector, for migraine patients.

Item

http://www.wikidata.org/entity/Q36967962

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Human factors validation study of 3 mg sumatriptan autoinjector, for migraine patients.

@en

type

Item

label

Human factors validation study of 3 mg sumatriptan autoinjector, for migraine patients.

@en

prefLabel

Human factors validation study of 3 mg sumatriptan autoinjector, for migraine patients.

@en

P1476

Human factors validation study of 3 mg sumatriptan autoinjector, for migraine patients.

@en

P2093

Anthony D Andre

http://www.w3.org/2001/XMLSchema#string

Elimor Brand-Schieber

http://www.w3.org/2001/XMLSchema#string

Margarita Ramirez

http://www.w3.org/2001/XMLSchema#string

Rajesh Kumar

http://www.w3.org/2001/XMLSchema#string

Sagar Munjal

http://www.w3.org/2001/XMLSchema#string

Will Valladao

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence-Based Treatments for Adults with Migraine

A novel needle for subcutaneous injection of interferon beta-1a: effect on pain in volunteers and satisfaction in patients with multiple sclerosis

Treatment of acute migraine headache.

Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference.

Comparative aspects of triptans in treating migraine.

Impact of a modified needle tip geometry on penetration force as well as acceptability, preference, and perceived pain in subjects with diabetes.

Triptan therapy in migraine.

Acute and preventive treatment of migraine.

The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies.

The acute treatment of migraine in adults: the american headache society evidence assessment of migraine pharmacotherapies.

P304

131-137

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/MDER.S105899

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27313479

http://www.w3.org/2001/XMLSchema#string

P921

migraine disorder

ergonomics

P932

4892851

http://www.w3.org/2001/XMLSchema#string

Human factors validation study of 3 mg sumatriptan autoinjector, for migraine patients.

about

P2860

P2860

Human factors validation study of 3 mg sumatriptan autoinjector, for migraine patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932